Art

J-GLOBAL ID：201802263222268026   Reference number：18A2171606

First report of the isolation of bla _IMI-1-producing colistin-heteroresistant Enterobacter cloacae in Japan, September 2016

2016年9月,日本におけるbla_IMI-1産生コリスチンヘテロ耐性Enterobacter cloacaeの分離の最初の報告

Author (20)： Tarumoto Norihito (Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan) ,  Tarumoto Norihito (Center for Clinical Infectious Diseases and Research, Saitama Medical University, Saitama, Japan) ,  Kodana Masahiro (Clinical Laboratory Medicine, Saitama Medical University Hospital, Saitama, Japan) ,  Watanabe Noriyuki (Clinical Laboratory, International Medical Center, Saitama Medical University, Saitama, Japan) ,  Sakai Jun (Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan) ,  Sakai Jun (Center for Clinical Infectious Diseases and Research, Saitama Medical University, Saitama, Japan) ,  Imai Kazuo (Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan) ,  Imai Kazuo (Center for Clinical Infectious Diseases and Research, Saitama Medical University, Saitama, Japan) ,  Yamaguchi Toshiyuki (Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan) ,  Yamaguchi Toshiyuki (Center for Clinical Infectious Diseases and Research, Saitama Medical University, Saitama, Japan) ,  Taji Yoshitada (Clinical Laboratory, International Medical Center, Saitama Medical University, Saitama, Japan) ,  Ebihara Yasuhiro (Department of Laboratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan) ,  Murakami Takashi (Center for Clinical Infectious Diseases and Research, Saitama Medical University, Saitama, Japan) ,  Murakami Takashi (Department of Microbiology, Saitama Medical University, Saitama, Japan) ,  Maeda Takuya (Center for Clinical Infectious Diseases and Research, Saitama Medical University, Saitama, Japan) ,  Maeda Takuya (Department of Microbiology, Saitama Medical University, Saitama, Japan) ,  Mitsutake Kotaro (Center for Clinical Infectious Diseases and Research, Saitama Medical University, Saitama, Japan) ,  Mitsutake Kotaro (Department of Infectious Diseases and Infection Control, International Medical Center, Saitama Medical University, Saitama, Japan) ,  Maesaki Shigefumi (Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan) ,  Maesaki Shigefumi (Center for Clinical Infectious Diseases and Research, Saitama Medical University, Saitama, Japan)
Material： Journal of Infection and Chemotherapy  (J Infect Chemother)
Volume： 24  Issue： 11  Page： 941-943  Publication year： Nov. 2018 
JST Material Number： L2852A  ISSN： 1341-321X  Document type： Article
Article type： 短報  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： Japan ,...
Semi thesaurus term： *Enterobacteriaceae ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A2171606&from=J-GLOBAL&jstjournalNo=L2852A") }}

Author keywords (5)： bla _IMI-1 ,  Carbapenemase ,  Enterobacter cloacae ,  Colistin ,  Heteroresistant

JST classification (2)： Microorganism tests  (GC02030H) ,  Clinical application of antibiotics acting on pathogenic organisms  (GX05030N)

Substance index (1)： Levofloxacin

Reference (15)：

• Rasmussen BA, Bush K, Keeney D, Yang Y, Hare R, O'Gara C, et al. Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob Agents Chemother 1996;40:2080-6.
• Performance standards for antimicrobial susceptibility testing. M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute; 2014.
• Mollet C, Drancourt M, Raoult D. rpoB sequence analysis as a novel basis for bacterial identification. Mol Microbiol 1997;26:1005-11.
• European Committee on Antimicrobial Susceptibility Testing. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Version 6.0, December 2016. Basel, Switzerland: European Committee on Antimicrobial Susceptibility Testing; 2016.
• El-Halfawy OM, Valvano MA. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev 2015;28:191-207.

Terms in the title (4)： 日本 ,  耐性 ,  Enterobacter ,  報告